September 20, 2018
1 min read
Save

Symposium supports theme of Women in Medicine Month

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The American Medical Association deems September Women in Medicine Month, when the AMA Women Physicians Section honors physicians who support advancement of women in medical careers.

At the Women in Ophthalmology 2018 Summer Symposium in Ponte Vedra, Florida, AMA President Barbara L. McAneny, MD, addressed some of the goals of the AMA with regard to women in medicine, addressing the inequities women face in their medical careers. Other speakers similarly addressed challenges and opportunities, and presented clinical data as well. Read the highlights from the meeting:

 

AMA president advocates for more equitable future in medicine

American Medical Association President Barbara L. McAneny, MD, wants to energize women to enact change that will bring parity of leadership in “the house of medicine.” Read more.

 

Research explores work, wealth and worth for women in ophthalmology

Wage disparity in ophthalmology is a complex topic, with growing interest in research on career advancement, recognition and income of women, according to Ashvini Reddy, MD, associate professor at Dean McGee Eye Institute. Read more.

 

Note to women in ophthalmology: ‘It is your time’

The year 2024 will be a key time for women in ophthalmology, according to George B. Bartley, MD, CEO of the American Board of Ophthalmology. That is when, if trends continue, there will be an equal number of men and women undergoing ABO examinations to become board certified in ophthalmology. Read more.

 

No cases of bilateral endophthalmitis reported after same-day injections

No cases of bilateral endophthalmitis were reported in a large study of patients who received bilateral same-day intravitreal anti-VEGF injections, according to a poster. Read more.